Reuters logo
BUZZ-India's Biocon hits record high; EU regulator OKs marketing applications for generic cancer drugs
December 1, 2017 / 4:29 AM / 13 days ago

BUZZ-India's Biocon hits record high; EU regulator OKs marketing applications for generic cancer drugs

** Biocon Ltd jumped as much as 3.6 pct to touch a record high of 447.60 rupees

** Co, partner Mylan N.V. said on Thursday that European Medicines Agency (EMA) accepted marketing authorization applications for proposed generic drugs trastuzumab, pegfilgrastim

** Trastuzumab is used as a treatment for breast and gastric cancers while pegfilgrastim is used to bolster neutrophils, a kind of white blood cell, in cancer patients treated with chemotherapy

** Up to Thursday’s close, stock had risen 36.49 pct this year

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below